LivingGLP1
Study S000021

Combatting Muscle Loss in Obese Adult Patients on GLP-1 Medications Through Dietary Counseling and Exercise During Treatment

Registration

Registration
NCT07554417
Study type
INTERVENTIONAL
Allocation
RANDOMIZED
Phase
PHASE4
Masking
NONE
Status
NOT_YET_RECRUITING
Enrollment
20
Start
2026-04-06
Primary completion
2026-06-29
Lead sponsor
William Marsh Rice University
Conditions
GLP - 1; Obesity & Overweight; Muscle Loss; Exercise Intervention; Dietary Assessment
Interventions
DRUG:Semaglutide; BEHAVIORAL:Dietary Counseling; BEHAVIORAL:Exercise
Results posted
FALSE
Individual participant data sharing
YES

Registered primary outcomes

  • Change in Skeletal Muscle Mass [Baseline to 12 weeks]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.